Karl Guo, Ph.D., joined Genscience as a Translational Geneticist in 2024, and his primarily role is supporting the identification and prioritization of drug targets. Karl has a background in computational biology, statistical genetics, and translational genetics and brings over a decade of pharma and biotech experience. Prior to Genscience, Karl was the Director of Translational Genetics at Insitro. Prior to Insitro, Karl was a Director of Computational Biology at GlaxoSmithKline.

Selected Publications

From Prescription to Transcription: Genome Sequence as Drug Target

Identification of HKDC1 and BACE2 as Genes Influencing Glycemic Traits During Pregnancy Through Genome-Wide Association Studies

Machine learning across multiple imaging and biomarker modalities in the UK Biobank improves genetic discovery for liver fat accumulation